Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
137.20B
Market cap137.20B
Price-Earnings ratio
50.19
Price-Earnings ratio50.19
Dividend yield
Dividend yield
Average volume
8.54M
Average volume8.54M
High today
High today
Low today
Low today
Open price
$94.38
Open price$94.38
Volume
0.00
Volume0.00
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

Boston Scientific(BSX) stock is priced at $92.59, giving the company a market capitalization of 137.2B. It carries a P/E multiple of 50.19.

Boston Scientific(BSX) stock opened on 2025-12-10 at $94.38. The price climbed to — and dipped to —.

Boston Scientific(BSX) shares are trading with a volume of 0, against a daily average of 8.54M.

In the last year, Boston Scientific(BSX) shares hit a 52-week high of $109.50 and a 52-week low of $85.98.

In the last year, Boston Scientific(BSX) shares hit a 52-week high of $109.50 and a 52-week low of $85.98.

BSX News

Simply Wall St 18h
Boston Scientific: Is the Recent Pullback Creating a New Valuation Opportunity?

Boston Scientific (BSX) has quietly pulled back, with shares down about 4% over the past week and roughly 13% over the past 3 months. This may offer investors a...

Boston Scientific: Is the Recent Pullback Creating a New Valuation Opportunity?
TipRanks 1d
Boston Scientific’s Strong Growth Potential in EP Market Justifies Buy Rating

In a report released yesterday, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific, with a price target of $120.00. TipRa...

Nasdaq 2d
PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But wh...

PAHC vs. BSX: Which Stock Is the Better Value Option?

Analyst ratings

94%

of 36 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

More BSX News

Nasdaq 2d
Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

Peter Lynch Detailed Fundamental Analysis - BSX

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.